Fennec Pharmaceuticals Inc (FENC) stock news · rev $44.6M
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
This FENC news page leads with what Fennec Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for FENC yet. We will not pad this page with generic market recap.
Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FENC stock page; for the tape open the quote page.
FENC stock news FAQ
What are FENC's latest revenue and net income?
Latest cached Fennec Pharmaceuticals Inc (FENC) revenue for Dec 31, 2025 was $44.6M. Net income was -$9.7M. Statements: https://lician.com/financials/fenc
How did FENC revenue change from the prior cached period?
Cached Fennec Pharmaceuticals Inc (FENC) revenue was down 6.1% from $47.5M (Dec 31, 2024) to $44.6M (Dec 31, 2025). Statements: https://lician.com/financials/fenc
What is FENC's market cap?
Fennec Pharmaceuticals Inc (FENC) market cap is $302.2M on the latest cached fundamentals snapshot.
What kind of company is FENC?
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Where is FENC stock news listed?
Cached stock news for Fennec Pharmaceuticals Inc (FENC) is listed at https://lician.com/news/fenc. Filings: https://lician.com/sec/fenc
Not investment advice.